Jason Pontin

A View from Jason Pontin

Purple America

The Daily Browse has a fascinating map depicting congressional support for increased funding of embryonic stem cell research. On Wednesday, Representatives voted 238 to 194 to support federal funding–short of the two-thirds majority required to override Mr. Bush’s promised…

  • May 27, 2005

The Daily Browse has a fascinating map depicting congressional support for increased funding of embryonic stem cell research. On Wednesday, Representatives voted 238 to 194 to support federal funding–short of the two-thirds majority required to override Mr. Bush’s promised veto of any bill. In other words, in a vote where the Republican whips did not enforce Party discipline, and where Congressmen and women voted to please their conscience or constituents, most Representatives supported federal investment in the new science. The President’s uncomplicated, unwavering distaste for stem cell research is not shared by many Americans.

Technorati tag:

Tech Obsessive?
Become an Insider to get the story behind the story — and before anyone else.

Subscribe today

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

Want more award-winning journalism? Subscribe to Insider Premium.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

    Access to the Magazine archive. Over 24,000 articles going back to 1899 at your fingertips.

    Special Discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look. Exclusive early access to stories.

    Insider Conversations. Listen in as our editors talk to innovators from around the world.

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.